The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.
Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.
Investigators assessed outcomes 5 years after bariatric surgery among patients with obesity and type 2 diabetes.
A team of investigators used genetic risk scores for type 1 diabetes and type 2 diabetes to identify genetic associations across racial and ethnic groups of youth in the United States.
Investigators evaluated the effect of genomics-enhanced, questionnaire-based risk tools on polygenic risk scores for coronary heart disease and type 2 diabetes.
Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D).
Investigators conducted a scoping review of randomized controlled trials that evaluated the impact of cognitive behavioral therapy on symptoms of depression and anxiety among patients with type 2 diabetes.
Researchers sought to determine the cost-effectiveness of Roux-en-Y gastric bypass, medical therapy, and sleeve gastrectomy in patients with severe obesity and T2D.